Lars Ek (Former)

1 – 10 of 12

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/lung-lek?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2022
Mark Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience
Karadzovska-Kotevska, Marija ^LU ; Brunnström, Hans ^LU ; Kosieradzki, Jaroslaw ^LU ; Ek, Lars ^LU ; Estberg, Christel ^LU ; Staaf, Johan ^LU ; Barath, Stefan ^LU and Planck, Maria ^LU (2022) In PLoS ONE 17(2 February).
- Contribution to journal › Article
Mark Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
Gezelius, Emelie ^LU ; Bendahl, Pär Ola ^LU ; Gallo, Widet ^LU ; de Oliveira, Kelin Gonçalves ^LU ; Ek, Lars ^LU ; Bergman, Bengt ; Sundberg, Jan ; Melander, Olle ^LU and Belting, Mattias ^LU (2022) In Cancers 14(5). p.1-14
- Contribution to journal › Article
2019
Mark Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
Gezelius, E. ^LU ; Bendahl, P. O. ^LU ; Gonçalves de Oliveira, K. ^LU ; Ek, L. ^LU ; Bergman, B. ; Sundberg, J. ; Strandberg, K. ^LU ; Krämer, R. and Belting, M. ^LU (2019) In European Journal of Cancer 118. p.82-90
- Contribution to journal › Article
2018
Mark COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer
Gulyas, Miklos ; Mattsson, Johanna Sofia Margareta ; Lindgren, Andrea ; Ek, Lars ^LU ; Lamberg Lundström, Kristina ; Behndig, Annelie ; Holmberg, Erik ; Micke, Patrick and Bergman, Bengt (2018) In Acta Oncologica 57(2). p.244-250
- Contribution to journal › Article
Mark Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
Ek, L. ^LU ; Gezelius, E. ^LU ; Bergman, B. ; Bendahl, P. O. ^LU ; Anderson, H. ^LU ; Sundberg, J. ; Wallberg, M. ^LU ; Falkmer, U. ; Verma, S. and Belting, M. ^LU (2018) In Annals of Oncology 29(2). p.398-404
- Contribution to journal › Article
Mark Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer : A sub-study of RASTEN - A randomized trial with low molecular weight heparin
Gezelius, E. ^LU ; Flou Kristensen, A. ; Bendahl, P. O. ^LU ; Hisada, Y. ; Risom Kristensen, S. ; Ek, L. ^LU ; Bergman, B. ; Wallberg, M. ^LU ; Falkmer, U. and Mackman, N. , et al. (2018) In PLoS ONE 13(11).
- Contribution to journal › Article
2017
Mark Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
Lindquist, Kajsa Ericson ^LU ; Karlsson, Anna ^LU ; Levéen, Per ; Brunnström, Hans ^LU ; Reuterswärd, Christel ^LU ; Holm, Karolina ^LU ; Jönsson, Mats ^LU ; Annersten, Karin ^LU ; Rosengren, Frida ^LU and Jirström, Karin ^LU , et al. (2017) In Oncotarget 8(21). p.34796-34810
- Contribution to journal › Article
2013
Mark Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
Sorenson, Sverre ; Fohlin, Helena ; Lindgren, Andrea ; Lindskog, Magnus ; Bergman, Bengt ; Sederholm, Christer ; Ek, Lars ^LU ; Lamberg, Kristina and Clinchy, Birgitta (2013) In European Journal of Cancer 49(1). p.115-120
- Contribution to journal › Article
Mark Radiological and clinical outcomes of using Chartis (TM) to plan endobronchial valve treatment
Herth, Felix J. F. ; Eberhardt, Ralf ; Gompelmann, Daniela ; Ficker, Joachim H. ; Wagner, Manfred ; Ek, Lars ^LU ; Schmidt, Bernd and Slebos, Dirk-Jan (2013) In European Respiratory Journal 41(2). p.302-308
- Contribution to journal › Article
2011
Mark Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
Koch, Andrea ; Bergman, Bengt ; Holmberg, Erik ; Sederholm, Christer ; Ek, Lars ^LU ; Kosieradzki, Jaroslaw ^LU ; Lamberg, Kristina ; Thaning, Lars ; Ydreborg, Sven-Olof and Sorenson, Sverre (2011) In European Journal of Cancer 47(10). p.1546-1555
- Contribution to journal › Article

« previous
1
2
next »